Twin Capital Management Inc. Has $5.87 Million Stock Position in Agilent Technologies Inc (NYSE:A)
Twin Capital Management Inc. trimmed its stake in shares of Agilent Technologies Inc (NYSE:A) by 41.7% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 78,573 shares of the medical research company’s stock after selling 56,097 shares during the quarter. Twin Capital Management Inc.’s holdings in Agilent Technologies were worth $5,867,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. Flagship Harbor Advisors LLC raised its position in shares of Agilent Technologies by 139.0% during the 2nd quarter. Flagship Harbor Advisors LLC now owns 349 shares of the medical research company’s stock valued at $26,000 after acquiring an additional 203 shares during the last quarter. Liberty Wealth Management LLC bought a new stake in shares of Agilent Technologies during the 2nd quarter valued at $29,000. Destination Wealth Management raised its position in shares of Agilent Technologies by 100.0% during the 1st quarter. Destination Wealth Management now owns 400 shares of the medical research company’s stock valued at $32,000 after acquiring an additional 200 shares during the last quarter. Coastal Capital Group Inc. bought a new stake in shares of Agilent Technologies during the 2nd quarter valued at $32,000. Finally, Financial Gravity Wealth Inc. bought a new stake in shares of Agilent Technologies during the 1st quarter valued at $52,000.
Several equities analysts have recently issued reports on the stock. Wolfe Research assumed coverage on shares of Agilent Technologies in a report on Thursday, May 30th. They issued a “peer perform” rating for the company. Bank of America cut shares of Agilent Technologies from a “buy” rating to a “neutral” rating and set a $76.00 price target on the stock. in a research report on Tuesday, July 16th. ValuEngine cut shares of Agilent Technologies from a “buy” rating to a “hold” rating in a research report on Friday, July 12th. Robert W. Baird reissued an “outperform” rating and set a $82.00 price target (up from $79.00) on shares of Agilent Technologies in a research report on Thursday. Finally, Piper Jaffray Companies boosted their price target on shares of Agilent Technologies from $83.00 to $86.00 and gave the stock an “overweight” rating in a research report on Thursday. One analyst has rated the stock with a sell rating, five have given a hold rating and ten have assigned a buy rating to the company’s stock. Agilent Technologies presently has a consensus rating of “Buy” and an average price target of $84.15.
Agilent Technologies (NYSE:A) last released its quarterly earnings results on Wednesday, August 14th. The medical research company reported $0.76 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.72 by $0.04. The firm had revenue of $1.27 billion for the quarter, compared to analysts’ expectations of $1.24 billion. Agilent Technologies had a net margin of 22.25% and a return on equity of 19.71%. The business’s revenue was up 5.6% on a year-over-year basis. During the same period in the prior year, the firm earned $0.67 EPS. Equities analysts expect that Agilent Technologies Inc will post 3.05 earnings per share for the current year.
The firm also recently announced a quarterly dividend, which was paid on Wednesday, July 24th. Shareholders of record on Tuesday, July 2nd were given a dividend of $0.164 per share. The ex-dividend date of this dividend was Monday, July 1st. This represents a $0.66 dividend on an annualized basis and a dividend yield of 0.94%. Agilent Technologies’s payout ratio is presently 23.66%.
Agilent Technologies Profile
Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates through three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; laboratory software and information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps; and measurement technologies.
Further Reading: Net Income
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.